Digital Content 
NEWS #PharmaBuzz
10 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/zepzelca-lurbinectedin-and-atezolizumab-tecentriq-combination-granted-us-fda-priority-review-for-first-line-maintenance-treatment-of-extensive-stage-small-cell-lung-cancer-302477581.html
07 Jun 2025
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/health-rounds-roches-tecentriq-reduces-recurrence-deaths-certain-colon-cancer-2025-06-06/
04 Jun 2025
// BIOSPACE
https://www.biospace.com/drug-development/roche-and-jazz-link-drug-combo-to-improved-survival-in-phase-iii-lung-cancer-trial
02 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-announces-zepzelca-lurbinectedin-and-atezolizumab-tecentriq-combination-significantly-improves-survival-as-first-line-maintenance-therapy-for-extensive-stage-small-cell-lung-cancer-302470965.html
31 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/31/3091401/0/en/Xilio-Therapeutics-Announces-Updated-Phase-2-Data-for-Vilastobart-a-Tumor-Activated-Anti-CTLA-4-in-Combination-with-Atezolizumab-in-Patients-with-Metastatic-Microsatellite-Stable-C.html
27 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/kahr-bio-announces-oral-presentation-of-phase-2-study-of-dsp107-in-combination-with-anti-pd-l1-in-colorectal-cancer-at-2025-asco-annual-meeting-302465659.html
Share 